MedTrace Logo

Ulmus Macrocarpa Hance Extract and Lipid Profile

NCT03773315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-28

No results posted yet for this study

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Ulmus Macrocarpa Hance extract on lipid profile in adults with dyslipidemia for 12 weeks.

Conditions

  • Dyslipidemias

Interventions

DIETARY_SUPPLEMENT

UMH extract

Schisandra chinensis extract 500 mg/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Starch placebo 500 mg/day for 12 weeks

Sponsors & Collaborators

  • Sang Yeoup Lee

    lead OTHER

Principal Investigators

  • Sang Yeoup Lee · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2020-02-14
Completion
2020-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03773315 on ClinicalTrials.gov